Strategic National Stockpile | Global Biodefense

Menu

Latest stories

US Invests Additional 44 Million in Smallpox Vaccine Manufacturing

Biosecurity and Biodefense Industry News

SIGA, USAMRIID Enter Agreement to Evaluate Post-Exposure Prophylactic for Smallpox

More on pathogens and preparedness

CDC to Award Contract to Emergent for 9 Million Doses of Smallpox Vaccine

by Global Biodefense August 12, 2018, 3:36 pm
FBI Seeks Tamiflu Supplier for Pandemic Flu Preparedness Program

by Global Biodefense July 12, 2018, 7:58 am
Health and Human Services Biodefense Budget Oversight
Project BioShield: HHS Purchases Anthrax Countermeasure from Elusys Therapeutics

by Global Biodefense April 23, 2018, 3:55 pm
U.S. Seeks to Develop Late-Stage Smallpox Antivirals

by Global Biodefense February 14, 2018, 1:35 pm
Bavarian Nordic Highlights Smallpox Orders, Vaccine Development

by Global Biodefense November 10, 2017, 8:40 am
First Shipment of ANTHIM Anthrax Treatment Delivered to Strategic National Stockpile
Biodefense Headlines – October 1, 2017

by Stephanie Lizotte October 1, 2017, 3:16 pm
Emergent BioSolutions to Acquire Smallpox Vaccine Business from Sanofi

by Global Biodefense July 18, 2017, 4:22 pm
CDC Stockpile Trainer Helps Other Countries Improve Supply Chain Preparedness

by Global Biodefense February 28, 2017, 2:31 pm
Elusys Delivers Anthrax Countermeasure Order, Gains Funding for Lyophilization Effort
HHS Releases 2016 PHEMCE Strategy and Implementation Plan

by Global Biodefense January 5, 2017, 12:55 pm

Congratulations. You've reached the end of the internet.

Back to Top

Close

close